SCHEMBL7674302

SCHEMBL7674302

CCCCn1cnc2c(OC)nc(Nc3ccc(OC)nc3)nc21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 7/20 0.44
CCNE1 P24864 7/20 0.44
CDK2 P24941 7/20 0.44
CTSL P07711 3/20 0.39
JAK2 O60674 2/20 0.39
PTK2 Q05397 2/20 0.39
EGFR P00533 1/20 0.39
FGFR1 P11362 1/20 0.39
MEN1 O00255 1/20 0.39
PABPC1 P11940 1/20 0.39
KMT2A Q03164 1/20 0.39
POLA1 P09884 1/20 0.37
CDK1 P06493 1/20 0.37
HDAC1 Q13547 2/20 0.37
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
ADORA2A P29274 1/20 0.36
NR3C1 P04150 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7661594 0.94 CDK2 (0.43) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7674135 0.94 PDGFRA (0.43) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7661510 0.91 PDGFRA (0.41) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7672877 0.90 PDGFRA (0.41) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7666161 0.90 PDGFRA (0.41) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7661549 0.90 PDGFRA (0.40) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7666083 0.90 PDGFRA (0.42) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7668775 0.90 PDGFRA (0.42) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7667620 0.89 PDGFRA (0.41) PDGFRACCNE1CDK2CTSLJAK2
SCHEMBL7670050 0.89 CDK2 (0.45) PDGFRACCNE1CDK2CTSLCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US disclosed
US-6407237-B1 SALT FORMATION WITH POTASSIUM HYDROXIDE; PRECIPITATION INETHANOL; CRYSTALLIZATION NEOTHERAPEUTICS, INC. 2002-06-18 US disclosed